APP and Alzheimer disease: Bush and colleagues treated an APP transgenic mouse with a CuZn chelator, clioquinol (8-hydroxy quinoline), showing the effective removal of plaque depositions [57]; however, it might alter the homeostasis of copper and counteract the intracellular copper-depleting effects of APP in initial clinical trials of the treatment of AD [58].